Morgan Stanley has increased its investment rating on insurer Marsh & McLennan. From “equal weight” to “overweight.”
An analyst reported that the company’s stock price decline has been overdone given Marsh & McLennan’s variety of earnings mix, which includes profits from its fast-growing insurance brokerage segment.
According to the analyst, MMC is expected to generate $1.3 billion for free cash flow during the year.
Was this article valuable?
Here are more articles you may enjoy.
Nuclear Verdicts Go Boom, Increase 40.7% in 2025 
CIAB Survey: Overall Soft Market Conditions Continue in Q2 
Judge Nixes Uber’s RICO Suit Alleging NY Lawyers, Doctors Conspired on Auto Claims 
Four Patients Affected, One Paralyzed, After Drug Mix-Up at Nashville Hospital 
